Tribio Anti-Human DLL3 & CD47 Bispecific Antibody (TBS10430)
$369.00 – $1,479.00
| SKU | Stock | SIZE (mg) | Price | Quantity | ||
|---|---|---|---|---|---|---|
| TBS10430-100 | Yes | 100 UG | $369.00 | |||
| TBS10430-1 | Yes | 1 MG | $1,479.00 |
- Description
- Terms
- Additional information
- Reviews (0)
Description
Description: Tribio DLL3 & CD47 Bispecific Antibody is an engineered antibody that simultaneously binds DLL3 on tumor cells and CD47 on cancer cells, enhancing macrophage-mediated phagocytosis and anti-tumor immune responses. It is commonly used in cancer immunotherapy research for DLL3-positive tumors such as small cell lung cancer.
Applications: ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Species reactivity: Human
Host species: Human
Target: Bispecific, Drosophila Delta homolog 3, Delta3, Delta-like protein 3, DLL3, Leukocyte surface antigen CD47, CD47, Antigenic surface determinant protein OA3, IAP, Integrin-associated protein, Protein MER6, MER6
Isotype: IgG1-kappa (CLC)
Accession/UniProt: Q9NYJ7 & Q08722
Concentration: 3 mg/ml
Purity: >95%
Formulation: Liquid
Storage buffer: 0.01M PBS, pH 7.4
Purification: Protein A/G purified from cell culture supernatant.
Storage: Avoid repeated freeze-thaw cycles. -20°C for 12 months; -80°C for long-term storage.
Research use only.
Additional information
| SIZE (mg) | 1 MG, 100 UG |
|---|
Be the first to review “Tribio Anti-Human DLL3 & CD47 Bispecific Antibody (TBS10430)”
You must be logged in to post a review.
Reviews
There are no reviews yet.